Skip to main content
Premium Trial:

Request an Annual Quote

Set to Pocket $5M in Financing, InforSense Shuffles Execs

NEW YORK (GenomeWeb News) — Software company InforSense said today that it has received a $5 million financing commitment from existing investors, and that company founder Yike Guo will be stepping down from the CEO position to serve as chief technology officer and head of innovation.

David Bennett, who joined the company in January 2008 as executive vice president of worldwide sales, has been appointed the company's new CEO, effective immediately.

The company, which has offices in London and Cambridge, Mass., said it plans to use the funding to invest in technology and infrastructure, and to expand its offerings, which include a suite of visual and predictive capabilities for science and business uses.

InforSense did not identify the investors involved in the round, but said that it included members of its executive team.

The privately held firm said that the funding commitment follows "consecutive record revenue quarters" that have resulted in year-over-year growth of around 30 percent.

Filed under

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.